Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome-Reference-Cited by-同舟云学术

Anti-CCP antibodies measured at disease onset help identify seronegative rheumatoid arthritis and predict radiological and functional outcome

Published:2005-11-15 Issue:4 Volume:45 Page:478-480
ISSN:1462-0332
Container-title:Rheumatology
language:en
Short-container-title:

Author:

Quinn M. A.,Gough A. K. S.,Green M. J.,Devlin J.,Hensor E. M. A.,Greenstein A.,Fraser A.,Emery P.

Publisher

Oxford University Press (OUP)

Subject

Pharmacology (medical),Rheumatology

Link

http://academic.oup.com/rheumatology/article-pdf/45/4/478/9448052/kei203.pdf

Reference23 articles.

1. Boers M. Understanding the window of opportunity concept in early rheumatoid arthritis. Arthritis Rheum2003;48:1771–4.

2. Quinn MA, Emery P. Window of opportunity in early rheumatoid arthritis: possibility of altering the disease process with early intervention. Clin Exp Rheumatol2003;21(Suppl. 31):S154–7.

3. Quinn MA, Conaghan PG, Emery P. The therapeutic approach of early intervention for rheumatoid arthritis: what is the evidence? Rheumatology2001;40:1211–20.

4. Arnett FC, Edworthy SM, Bloch DA et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum1988;3:315–24.

5. Green MJ M-OH, McGonagle et al. Persistence of mild early inflammatory arthritis: the importance of disease duration, rheumatoid factor and the shared epitope. Arthritis Rheum1999;42:2184–8.

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Factors associated with resolution of ultrasound subclinical synovitis in anti-CCP-positive individuals with musculoskeletal symptoms: a UK prospective cohort study;The Lancet Rheumatology;2024-02

2. A Comparison of Anti-Cyclic Citrullinated Peptides (Ccp3 and Ccp3.1) Autoantibody Tests for Rheumatoid Arthritis;2024

3. Characterization and use of the ECV304 autoantigenic citrullinome to understand anti-citrullinated protein/peptide autoantibodies in rheumatoid arthritis;Arthritis Research & Therapy;2022-01-13

4. Anti-cyclic-citrullinated-protein-antibodies in psoriatic arthritis patients: how autoimmune dysregulation could affect clinical characteristics, retention rate of methotrexate monotherapy and first line biotechnological drug survival. A single center retrospective study.;Therapeutic Advances in Chronic Disease;2021-01

5. Third‐Generation Anti–Cyclic Citrullinated Peptide Antibodies Improve Prediction of Clinical Arthritis in Individuals at Risk of Rheumatoid Arthritis;Arthritis & Rheumatology;2020-09-07